Ignite Creation Date:
2024-05-06 @ 9:33 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03013491
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2016-12-26
Brief Title:
PROCLAIM-CX-072 A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas
Sponsor:
CytomX Therapeutics
Organization:
CytomX Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
None
Primary Completion Date:
2021-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-26
First Submit QC Date:
January 5 2017
Study First Post Date:
2017-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-07
Last Update Post Date:
2022-02-09
Last Update Post Date Type:
ACTUAL